Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Dosing completed in phase II trial of GCS-100 for chronic kidney disease

Feb. 24, 2014

Regulus Therapeutics nominates RG-012 as candidate for Alport syndrome

Feb. 21, 2014

Japanese researchers claim new prostanoid EP1 receptor antagonists

Feb. 17, 2014

Astellas reports melatonin agonists for urinary incontinence

Jan. 29, 2014

Japan Tobacco and Torii gain approval for Riona Tablets in Japan

Jan. 17, 2014

Extended treatment phase of ZS-9 phase III trial in hyperkalemia meets endpoint

Jan. 15, 2014

Proteon obtains E.U. orphan drug status for PRT-201 for hemodialysis vascular access

Jan. 10, 2014

Development and characterization of an orally available antifibrotic drug to treat renal fibrosis

Jan. 2, 2014

Novel autotaxin inhibitors synthesized by Roche

Dec. 31, 2013

Evolva and Serodus sign EV-077 licensing agreement

Dec. 31, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...